Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shaldon

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Blood Purification|January 1, 1996
Retention of cytokine-inducing substances inside high-flux dialyzersV Lufft, A Mahiout, S Shaldon, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1980
Vascular stability during hemofiltrationS Shaldon, M C Beau, G Deschodt, et al.
Nephron|January 1, 1986
Human interleukin-1 production during hemodialysisM Bingel, G Lonnemann, S Shaldon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1997
Continuous administration of intravenous iron during haemodialysisC Granolleras, A Zein, R Oulès, et al.
British Medical Journal|July 24, 1971
Testosterone therapy for anaemia in maintenance dialysisS Shaldon, K M Koch, F Oppermann, et al.
Contributions to Nephrology|January 1, 1989
Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranesR Schindler, G Lonnemann, S Shaldon, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
Aluminium transfer in bicarbonate dialysis using a sorbent regenerative system: an in vitro studyB Branger, P Ramperez, N Marigliano, et al.
Contributions to Nephrology|January 1, 1987
Biological consequences of monocyte activation during hemodialysisC A Dinarello, G Lonnemann, M Bingel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Beta 2-microglobulin kinetics during haemofiltrationJ Floege, M Wilks, S Shaldon, et al.
Contributions to Nephrology|January 1, 1985
CAPD is a second-class treatmentS Shaldon, K M Koch, E Quellhorst, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Blood Purification|January 1, 1996
Retention of cytokine-inducing substances inside high-flux dialyzersV Lufft, A Mahiout, S Shaldon, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1980
Vascular stability during hemofiltrationS Shaldon, M C Beau, G Deschodt, et al.
Nephron|January 1, 1986
Human interleukin-1 production during hemodialysisM Bingel, G Lonnemann, S Shaldon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1997
Continuous administration of intravenous iron during haemodialysisC Granolleras, A Zein, R Oulès, et al.
British Medical Journal|July 24, 1971
Testosterone therapy for anaemia in maintenance dialysisS Shaldon, K M Koch, F Oppermann, et al.
Contributions to Nephrology|January 1, 1989
Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranesR Schindler, G Lonnemann, S Shaldon, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
Aluminium transfer in bicarbonate dialysis using a sorbent regenerative system: an in vitro studyB Branger, P Ramperez, N Marigliano, et al.
Contributions to Nephrology|January 1, 1987
Biological consequences of monocyte activation during hemodialysisC A Dinarello, G Lonnemann, M Bingel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Beta 2-microglobulin kinetics during haemofiltrationJ Floege, M Wilks, S Shaldon, et al.
Contributions to Nephrology|January 1, 1985
CAPD is a second-class treatmentS Shaldon, K M Koch, E Quellhorst, et al.
Pageof 16